Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Desmopressin and Bleeding Outcomes After Native Kidney Biopsy in Severe Renal Impairment
NCT07840313Completed
- Sponsor
- Sindh Institute of Urology and Transplantation
- Start
- Aug 2017
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
Open-label trial of desmopressin (2 arms), sponsored by Sindh Institute of Urology and Transplantation. Primary endpoint: Overall bleeding complications at 24 hours. Started Aug 2017; status: completed.
02
Drugs
desmopressin
Beyond the preview
Go deeper on NCT07840313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07840313.